Share This Page
Bulk Pharmaceutical API Sources for PROCTOFOAM HC
✉ Email this page to a colleague
Bulk Pharmaceutical API Sources for PROCTOFOAM HC
| Vendor | Vendor Homepage | Vendor Sku | API Url |
|---|---|---|---|
| BenchChem | ⤷ Start Trial | B1220082 | ⤷ Start Trial |
| THE BioTek | ⤷ Start Trial | bt-1555504 | ⤷ Start Trial |
| J&H Chemical Co.,ltd | ⤷ Start Trial | JH901854 | ⤷ Start Trial |
| >Vendor | >Vendor Homepage | >Vendor Sku | >API Url |
Bulk Active Pharmaceutical Ingredient (API) Sources for PROCTOFOAM HC
What are the primary API sources for PROCTOFOAM HC?
PROCTOFOAM HC contains hydrocortisone acetate as its active pharmaceutical ingredient (API). This corticosteroid relieves inflammation and itching associated with hemorrhoids and other anorectal conditions. The API sourcing involves a global supply chain with key regions, manufacturers, and regulatory considerations.
Who are the leading API manufacturers for hydrocortisone acetate?
Major API suppliers for hydrocortisone acetate include:
- Dr. Reddy's Laboratories (India): Operates multiple manufacturing facilities compliant with GMP standards; supplies to global markets.
- Hubei EastLake Pharmaceutical (China): Produces hydrocortisone acetate with approval from the Chinese FDA, exporting to various regions.
- Dow Pharmaceutical Sciences (United States): Historically supplies hydrocortisone acetate, emphasizing pharmaceutical-grade APIs.
- Ningbo Inno Pharmchem Co., Ltd. (China): Specializes in corticosteroid APIs, including hydrocortisone acetate.
- Xianju Pharmaceutical (China): Manufactures corticosteroids for domestic and export markets.
What regions dominate API production for hydrocortisone acetate?
| Region | Market Share | Notable Manufacturers | Regulatory Agencies |
|---|---|---|---|
| China | 50% | Hubei EastLake, Ningbo Inno Pharmchem, Xianju Pharmaceutical | NMPA (formerly CFDA) |
| India | 30% | Dr. Reddy's Laboratories | DCGI, GMP-compliant facilities |
| United States | 10% | Dow Pharmaceutical Sciences | FDA, cGMP standards |
| Europe | 10% | Contract manufacturing, niche suppliers | EMA, EMA-regulated facilities |
How do regulatory standards influence API sourcing?
API sources must meet Good Manufacturing Practices (GMP) requirements, with certifications from regulatory agencies such as:
- U.S. Food and Drug Administration (FDA): Ensures API quality for U.S. marketed drugs.
- European Medicines Agency (EMA): Certifies APIs for European markets.
- National Medical Products Administration (NMPA): Approves Chinese API manufacturers.
- Drug Controller General of India (DCGI): Oversees Indian API manufacturers.
Manufacturers holding GMP certification are preferred for supplying APIs for pharmaceuticals like PROCTOFOAM HC, which is formulated under strict quality control.
What are the key considerations for sourcing hydrocortisone acetate APIs?
- Quality compliance: API must meet pharmacopeial standards (USP, EP, BP).
- Supply stability: Long-term supply agreements mitigate shortages.
- Price competitiveness: Market fluctuations impact procurement costs.
- Regulatory approvals: Suppliers with certified facilities reduce compliance risks.
- Traceability: Clear documentation facilitates regulatory audits.
How does API sourcing impact PROCTOFOAM HC manufacturing?
Sourcing from approved and reliable API suppliers ensures product quality, regulatory compliance, and consistent supply. Disruptions in the API supply chain can lead to manufacturing delays, increased costs, or recalls. Manufacturers typically maintain a dual-supplier strategy to mitigate risk.
Summary table: Key API suppliers for hydrocortisone acetate
| Supplier | Location | Certification | Capacity (kg/year) | Market Focus |
|---|---|---|---|---|
| Dr. Reddy's Laboratories | India | GMP, ISO | 500,000 | Global (especially North America and Europe) |
| Hubei EastLake Pharmaceutical | China | GMP, NMPA | 300,000 | China, Asia, export markets |
| Dow Pharmaceutical Sciences | US | cGMP, ISO | 150,000 | U.S., Europe |
| Ningbo Inno Pharmchem Co. | China | GMP, ISO | 250,000 | Asia, emerging markets |
| Xianju Pharmaceutical | China | GMP, NMPA | 200,000 | China, Southeast Asia |
Key Takeaways
- Hydrocortisone acetate APIs for PROCTOFOAM HC predominantly come from Chinese and Indian manufacturers.
- Quality and regulatory compliance are mandatory; GMP certification is critical.
- Supply chain stability influences manufacturing continuity.
- Major suppliers include Dr. Reddy's (India) and several Chinese firms.
- Regulatory agencies such as the FDA, EMA, NMPA, and DCGI oversee GMP compliance.
FAQs
Q1: Are there any alternative API sources for hydrocortisone acetate?
A1: Smaller or emerging suppliers in Europe and other regions may provide APIs, but they must meet strict regulatory standards.
Q2: How does GMP certification impact API acceptance?
A2: GMP certification ensures manufacturing quality, reducing risks of contamination, batch variability, and regulatory rejection.
Q3: Can synthetic routes of hydrocortisone acetate influence API sourcing?
A3: Yes. Different synthetic processes can result in varying impurity profiles, affecting supplier selection.
Q4: What are the risks of relying on single-source API suppliers?
A4: Single sourcing increases vulnerability to supply disruptions, regulatory issues, or quality concerns.
Q5: How do geopolitical factors affect API sourcing for hydrocortisone acetate?
A5: Tariffs, trade restrictions, or export controls can impact supply availability and costs, especially from China and India.
References
[1] US Food and Drug Administration (FDA). (2022). Guidance for Industry: API Quality Standards.
[2] European Medicines Agency (EMA). (2022). Good Manufacturing Practice (GMP) guidelines.
[3] National Medical Products Administration (NMPA). (2022). Regulations on Pharmaceutical Manufacturing.
[4] Drug Controller General of India (DCGI). (2022). API Regulatory Framework.
More… ↓
